Ontology highlight
ABSTRACT: Background
Women seeking nonhormonal interventions for vulvovaginal, urinary, and sexual symptoms associated with genitourinary syndrome of menopause (GSM) may seek out complementary and alternative medicine or therapies (CAMs).Purpose
To summarize published evidence of CAMs for GSM.Data sources
Ovid MEDLINE, EMBASE, and CINAHL from inception through 11 December 2023.Study selection
Randomized controlled trials (RCTs) 8 weeks or more in duration that evaluated the effectiveness or harms of CAMs for postmenopausal women with GSM and reported 1 or more outcomes of interest, with sample sizes of 20 or more participants randomly assigned per group.Data extraction
Data were abstracted by 1 reviewer and verified by a second.Data synthesis
An eviden
SUBMITTER: Ullman KE
PROVIDER: S-EPMC12270004 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature